The medical technology group priced $700m of 2036 notes at 5.750% to fund a tender offer for its existing 2030 senior notes.

The medical technology group is buying back up to $250 million of its 2.032% notes due 2030, funded by a concurrent new bond offering as it looks to stretch out its debt maturity profile.

It has agreed a five-year partnership with Imperial College London to speed development of less invasive robotic surgery techniques for musculoskeletal conditions.

Smith Nephew has introduced the FLOW FLEXTEND COBLATION Wand, a hip-specific surgical instrument it says improves joint access and resection efficiency over fixed-angle alternatives.

The "burden of proof now rests firmly on execution", DB said in a note, whilst cutting targets and forecasts - but, stick with a Hold rating.

A new interdisciplinary expert consensus published in Germany sets out the first risk-based framework for using single-use negative pressure wound therapy on closed surgical incisions, with Smith+Nephew's PICO 7 device cited as a targeted option for high-risk patients.

Smith+Nephew has carried out the inaugural clinical procedures with its next‑generation CORI XT handheld robotics platform in both knee and shoulder arthroplasty, including what it describes as the first robotic shoulder arthroplasty cases performed in hospital and ambulatory surgery centre settings.